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ABSTRACT 
 
Background: Drugs are essential components of the health system and their rational use is vital 
to delivering quality and efficient healthcare services. However, inappropriate prescribing is a 
common rational drug use problem globally, particularly in developing countries including 
Nigeria. Despite measures to address this problem, inappropriate drug use continues to be a 
major public health problem in Nigeria.   
Aim: This study assessed rational drug use (RDU), with a focus on rational prescribing and 
factors affecting it, among primary healthcare providers working in primary healthcare facilities 
of a LGA in Northwestern Nigeria.  
Methods: The study was a cross sectional descriptive study and it included retrospective review 
of patient encounters and interviews with prescribing healthcare providers in sampled health 
facilities. Stratified random sampling method was used to select 20 public primary healthcare 
facilities and 30 patient encounters were drawn by systematic random sampling from each 
facility. One hundred and sixty three prescribing healthcare providers in the health facilities were 
also included in the study. Adapted WHO‘s drug use study tools and a structured self 
administered questionnaire were used to collect data. Data were analysed using Statistical 
Package for Social Sciences (SPSS Version 17) software and presented as contingency table with 
chi square test used to test for relationship between variables with statistical significance taken at 
p < 0.05.  Ethical approval was obtained from the University of the Western Cape Research 
Ethics Committee and Kaduna State Ministry of Health, and permission from local stakeholders. 
Confidentiality of individual patients, healthcare providers and health facilities data was 
maintained.  
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Results: The prescribing staff at the selected facilities were predominantly Nurses/Midwives and 
community health assistants with SCHEWs constituting the majority (60.8%). More than half 
(54.4%) of providers did not know about the concept of RDU. Similarly, the computed 
knowledge score of RDU revealed that the majority (74.4%) had poor knowledge of the concept. 
Knowledge was significantly associated with duration of service, providers‘ previous training in 
rational drug use and professional status (p<0.05), with the CHOs having better knowledge of 
RDU compared with other professional cadres. High antibiotic use (68.3% in retrospective 
review and 82.9% in survey)  and injection use (9.5% in retrospective review and 12% in survey)  
were found in the study with significant proportions of providers admitting that all cases of 
URTI should receive antibiotics (72.3% ) and that patients could be prescribed injections if they 
requested for it (35.3%). The Standing Order was the main source of information for the majority 
(50.6%) of providers and it served as the major influence affecting prescribing practices. 
Conclusion: This study revealed a poor understanding and knowledge of RDU among healthcare 
providers. High antibiotic and injection use also reflected providers‘ poor attitude to rational 
prescribing of these commodities. To improve prescribing practices at the PHC level, adequate 
staff skill mix, including physicians should be established. Since RDU knowledge was associated 
with prior training, curriculum development towards RDU and opportunities for in-service 
training should be provided to build prescribers capacity, in addition to instituting a system of 
rational drug use monitoring. Further research into rational drug use among different cadres of 
PHC healthcare providers is also recommended. 
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DEFINITIONS 
 
Drug use indicators  Indices used to measure performance in rational use of drugs. It   
comprises core indicators (measures prescribing practices of  
healthcare providers, patients‘ care, and health facility factors) and  
complementary indicators (additional measures of rational drug use) 
(WHO, 1993).  
 
Essential 
drugs/medicines  
Drugs that satisfy the priority health care needs of the population 
(WHO, 2000). 
Generic prescribing Drug prescribing using non-propriety titles for a pharmaceutical   
preparations (WHO, 2001). 
Rational Drug Use      
                                                      
Drug prescribing resulting in patients receiving medications appropriate 
to their clinical needs, in doses that meet their individual requirements 
for an adequate period of time and at lowest cost to them and their 
community (WHO, 2001). 
Standing Order         
 
A set of specific guidelines arranged by symptoms which defines how 
clients with different conditions should be cared for and designed to be 
used by community health workers and other health workers at the PHC 
setting in Nigeria (FMOH, 1995). 
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CHAPTER 1 
INTRODUCTION 
1.1 Introduction 
Drugs are vital components of the health system and their availability in health facilities is one of 
the most visible symbols of quality of care to consumers (Uzochukwu et al., 2002). In addition to 
drugs being available, their rational use has also been identified to be an essential ingredient in 
enhancing provision of quality  and efficient healthcare services (Chareonkul et al., 2002).  The 
World Health Organization (WHO) defined rational drug use  as ―when patients receive 
medications appropriate to their clinical needs, in doses that meet their individual requirements 
for an adequate period of time and at lowest cost to them and their community‖ (WHO, 1985). 
However, inappropriate, ineffective and inefficient use of drugs in health facilities are common 
public health problems globally (Garjani et al., 2009 ). Even though it is a global problem, 
inappropriate drug use is particularly prevalent in developing countries (Chuckwuani et al., 2002 
). The use of inappropriate or ineffective drugs, misuse of effective drugs, use of combination 
products with no justifiable advantage over other single preparations, and other irrational 
prescribing practices such as polypharmacy, non generic prescribing practices, overuse of 
antimicrobials and injections were reported as common practices in several developing countries 
(Hafeez et al., 2004).  
 
In many developing countries, including Nigeria, between 20-50% of the health budget is spent 
on pharmaceuticals (Govindaraj et al., 2000). Nevertheless, significant proportions of the 
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population in need of drugs still have limited access to them due to non-availability, high cost or 
inappropriate prescribing practices by healthcare providers.  Even though ensuring a regular 
supply of essential affordable drugs may improve the quality of care and attendance at health 
facilities, it may still not translate into optimal improvement in health outcomes if irrational use 
of these drugs continues to plague the health systems. In fact, in many developing countries, 
irrational drug use remains a major concern at all levels of healthcare but with preponderance at 
the primary care levels such as the PHC centres, and especially in rural areas where supervision 
and controls on the activities of healthcare providers are usually less rigorous. These practices 
often result in serious consequences such as, reduction in the quality of drug therapy, wastage of 
resources, increased treatment cost, increased risk for adverse drug reactions, and emergence of 
drug resistance (Siddiqi et al., 2002, Vaccheri et al., 2000).  
 
Worldwide, several efforts have been made to promote rational use of medicine including 
rational prescribing among healthcare providers. In 1985, the WHO Conference of Experts on 
the Rational Use of Drugs, held in Nairobi Kenya, served as an important landmark in the 
promotion of rational drug use around the world (WHO, 1985). The International Network for 
the Rational Use of Medicine (INRUD) was established in 1989 to conduct multidisciplinary 
intervention research to promote rational use of medicines. The first and second International 
Conferences on the Irrational Use of Medicine (ICIUM) were held in Chiang Mai, Thailand in 
1997 and 2004 respectively (WHO, 2004b). The two conferences provided avenues for national 
and international policy makers, program managers, researchers, clinicians, and other 
stakeholders to create awareness on irrational use of medicines and interventions to improve 
medicines use, especially in non-industrialized countries where the problem is more prevalent. 
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Moreover,  the 6
th
 World Health Assembly in 2007 through its  Resolution WHA60.16  provided 
recommendations to member countries, the secretary General of the United Nations and other 
stakeholders on measures needed to be adopted towards rational use of medicines (WHO, 
2004b). 
 
Similarly in the last two decades the WHO and other stakeholders have promoted rational use of 
medicines across the world, most especially in developing countries (WHO, 1994, WHO, 2006). 
Cardinal among its efforts was the Bamako Initiative which was launched in 1988 (Ebrahim, 
1993). The aim of this initiative was to provide strategic support for local governments in 
developing countries to assist them in strengthening the provision of primary healthcare (PHC) 
through ensuring a steady supply of essential drugs, promotion of drug prescription by generic 
names, as well as improving prescribing practices of health providers. More recently, 
interventions such as establishment of national committees to coordinate policies on medicine 
use, use of clinical guidelines, development and use of national essential medicines list, 
establishment of drug and therapeutics committees in districts and hospitals among others have 
been advocated to promote more rational use of medicines (WHO, 2002).  
 
In Nigeria, the essential drugs programme was first introduced in 1988 with financial and 
technical support from the WHO, United Nations‘ Children‘s Fund (UNICEF) and UK 
Department of International Development (DFID) (FMOH, 1994). At its inception this 
programme had the preparation of an essential drugs list and development of a system of rational 
use of drugs as part of its objectives (FMOH, 1994). Since then, several efforts at all levels of 
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government have been introduced to promote rational use of medicine among healthcare 
providers. Some of these efforts include establishment of a national committee on rational use of 
medicine, development of national essential medicine list and formulation of clinical treatment 
guidelines, whilst others include sensitization of healthcare providers and other stakeholders on 
rational use of medicine and training of healthcare providers about rational use of drugs (FMOH, 
2005). Despite these efforts, irrational use of medicine still continues to be a major problem in 
health facilities, most especially at the primary care level where the majority of the work force 
are of the lower cadres of health care providers (Olayemi et al., 2006). At this level of healthcare, 
continuous medical education among health workers and adequate supervision are often poor 
resulting in minimal or no information about medicines and their rational use (Pakenham-Walsh 
and Bukachi, 2009). 
 
As part of the global efforts at promoting rational use of medicine, INRUD generated indicators 
for assessment of drug use in health facilities (WHO, 1993). Over the years these indicators have 
been extensively field-tested and refined and have been used to assess rational use of medicines 
in health facilities in many parts of the world.  The indicators were designed to assess clinical or 
economic aspects of inappropriate use of medicines. In addition to this, it was also intended to 
serve as a supervisory tool in health facilities or to measure the effect of an intervention towards 
rational use of medicines (WHO, 1993).  Of these indicators, the core drug use indicators 
comprise prescribing indicators, patient care indicators and health facility indicators. The 
prescribing indicators assess prescribing practices of healthcare providers. Considering the 
important roles that prescribing practices play in rational use of medicines, this present study 
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therefore focused on prescribing practices of healthcare providers at the primary healthcare 
facilities in a local government area of Northwestern Nigeria. 
 
1.2 Problem statement 
Inappropriate prescribing is a major public health problem in Nigeria. Polypharmacy, non 
generic prescribing practices, misuse of antibiotics and overuse of injections are various forms of 
irrational use of medicines that have been described at all levels of healthcare in Nigeria. 
(Enwere et al., 2007, Akande and Ologe, 2007, Olayemi et al., 2006). Despite the various 
measures put in place to address these problems, the situation has not changed significantly as 
recent studies still report similar findings (Olayemi et al., 2006, Akande and Ologe, 2007, 
Adebayo and Hussain, 2009).  The direct implication of this is a reduction of quality of drug 
therapy. Besides the increased cost of treatment and wastage of resources, other problems 
associated with inappropriate prescribing include the increased risk of adverse drug reactions and 
emergence of drug resistance. Among the various types of inappropriate use of medicines, 
misuse of antibiotics and injections are particularly common in Nigeria. For example, a 2002 
WHO survey documented that 60% of antibiotics in Nigeria, were prescribed unnecessarily 
(WHO, 2006). Apart from the economic waste and non-optimal patient care that might result 
from this, anti-microbial resistance could also develop necessitating the use of newer more 
expensive antibiotics (Vaccheri et al., 2000, Siddiqi et al., 2002) . Similarly, in many healthcare 
settings in developing countries including Nigeria, misuse of injections and poor adherence to 
universal precautions have been noted to be particularly prevalent (Kermode, 2004, Jacob et al., 
2010). The misuse of injections coupled with practices such as re-use and use of non-sterilized 
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needles may increase the transmission of blood borne infections such as hepatitis and HIV, thus 
increasing the burden of morbidity and mortality resulting from these diseases.  
 
1.3 Rationale for the study  
Nigeria‘s health system has adopted the primary health care (PHC) approach which includes as 
one of its components provision of essential drugs, and for this to be successful rational use of 
essential drugs is a critical factor (FMOH, 2004). Prescribing practices of healthcare providers is 
a crucial component of rational drug use, as rational use translates into significant health gains 
for patients and the health system generally (WHO, 2006). Studies focusing on rational drug use 
and especially prescribing practices of healthcare providers at the primary health care level are 
therefore important in contributing to the overall success of PHC in the country and ultimately to 
the smooth functioning of its health system. A number of studies on providers‘ prescribing 
practices have been conducted in the southern part of Nigeria but there are few drug use studies 
from the northern part and more especially at the primary care level. This study documents drug 
use among primary healthcare providers in a local government area of Northwestern Nigeria and 
it is hoped that the findings will serve as a baseline for future drug use studies. The study also 
documents factors that affect rational drug use at this level of care, and it is hoped that these 
findings will create both awareness among health providers and other stakeholders of rational 
drug use, and will assist policy makers in further reviewing and implementing policies related to 
rational drug use. 
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1.4 Aim and objectives of the study  
Aim To assess rational drug use among healthcare providers working in public primary health 
care facilities in Zaria Local Government Area (LGA), Northwestern Nigeria.  
Specific objectives 
1. To assess the level of knowledge and attitude about rational drug use among healthcare 
providers in public primary healthcare facilities in Zaria LGA  
2. To determine the prescribing practices of healthcare providers in public primary 
healthcare facilities in Zaria LGA 
3. To determine factors that influence rational drug use by healthcare providers in public 
primary healthcare facilities in Zaria LGA. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Introduction  
Many drug use studies have been conducted around the world to assess rational use of medicines 
(WHO, 2004a). The WHO‘s drug use indicators have been used in most of these studies 
(Hogerzeil et al., 1993). These indicators are classified into core indicators and complementary 
indicators. The core indicators were developed to be used as measures of performance in three 
general areas related to the rational drugs use: prescribing practices by health providers, key 
elements of patient care including consultation and pharmaceutical dispensing, and availability 
of facility-specific factors such as drug policies and regulations which support rational use 
(WHO, 1993). Complementary indicators measure providers‘ effectiveness in use of non-
pharmaceutical therapies, cost considerations, adherence to treatment guidelines, quality of care 
received by patients and access to impartial drug information. These indicators are sometimes 
used in addition to core drug indicators, although they are often more difficult to obtain and are 
highly sensitive to the local context (WHO, 1993).  
 
The pioneering studies on drug use in health facilities started in late 1989 and early 1990s. The 
majority of these studies were designed to evaluate the impact of essential drug programmes on 
rational drug use in various countries with many focusing on the core drug use indicators 
(Hogerzeil et al., 1989, Walker et al., 1990, Bannenberg et al., 1991, Hogerzeil et al., 1993). 
These studies were generally aimed at describing the current prescribing practices and 
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monitoring specific drug use behavior in the countries where they were conducted. More recently 
however, in addition to assessing current prescribing practices, studies have focused on 
elucidating factors that influence rational use of medicines in health facilities and the evaluation 
of effectiveness of specific interventions aimed at addressing these problems in different settings 
(WHO, 1993). 
 
In Nigeria, most studies on rational drug use have focused on drug prescribing patterns among 
healthcare providers using the core drug use indicators and almost all of these studies have been 
carried out in the southern part of the country (Nwolisa et al., 2006 , Erah et al., 2003, Olayemi 
et al., 2006, Ibrahim, 2004, Ogunnowo and Asuzu, 2003, Odusanya, 2006, Enwere et al., 2007). 
Even though these studies documented the drug use profile in health facilities, many did not 
focus on the factors that were responsible for the pattern of drug use. The few studies that looked 
at factors influencing prescribing practices were conducted in secondary healthcare facilities 
(Erah et al., 2003, Adebayo and Hussain, 2009). For example, Erah et al. (2003), in addition to 
documenting prescribing practices, interviewed 40 prescribers about factors affecting prescribing 
practices. Similarly, the baseline study by Adebayo et al. (2009)  in a military hospital in Lagos, 
Southern Nigeria, documented the factors that influenced drug use among health workers in the 
that setting.  
 
2.2 Knowledge and attitude of healthcare providers on rational use of drugs 
Healthcare providers‘ knowledge of rational use of drugs is an important determinant of their 
prescribing behavior (Garjani et al., 2009 ). Despite this, studies that focused on providers‘ 
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knowledge as it relates to their prescribing behavior are still limited. In a study to assess the 
impact of an essential drug programme on availability and rational use of drugs in Yemen, 
Hogerzeil et al reported that healthcare workers that were trained on rational use of medicines 
scored slightly, but not significantly, better in a test on theoretical knowledge on rational drug 
use (Hogerzeil et al., 1989). However, the study noted considerable differences in the prescribing 
patterns in the study areas. Adebayo et al in a cross-sectional descriptive study of Nigerian army 
hospitals documented that only 12.1% of respondents, who were mainly physicians, could 
correctly detail the steps in rational prescribing practices (Adebayo and Hussain, 2010).  In a 
similar study among medical assistants in Ghana, Ofori- Adjei et al reported that improving 
prescribers‘ knowledge of rational drug use through in-service training improved their 
knowledge but not their prescribing behavior (Ofori-Adjei and Arhin, 1996). In contrast, a study 
carried out in Zimbabwe found that improving nurses‘ knowledge of rational drug use through 
on the job training improved their prescribing practices (Masango, 1994). These findings show 
that the success of training as a means of improving prescribers‘ knowledge and practice on 
rational drug use may be dependent on their professional status. 
 
2.3 Patterns of irrational drug use of drugs in health facilities 
Various patterns of irrational drug use have been described in several drug use studies. These 
include polypharmacy, irrational use of anti-microbial agents, and irrational use of injections 
(Olayemi et al., 2006, Otoom et al., 2010). Most of these studies were cross sectional descriptive 
studies that looked at current prescribing practices of health workers and adopted the WHO‘s 
drug use indicators and guidelines on how to investigate drug use in health facilities. 
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Polypharmacy is measured by average number of drugs per encounter, while the percentage of 
drugs prescribed by generic name measures the tendency of prescribers to prescribe using 
generic names, as opposed to brand (trade), names. The percentage of encounters with an 
antibiotic or injection measures the overall use of antibiotics or injections, which are two 
commonly overused and costly forms of drug therapy. The percentage of drugs prescribed from 
the essential drug list or drug formulary measures the degree to which prescribing practices 
conforms with national drug policy and treatment guidelines (WHO, 1993).  
 
 Even though there is no agreed reference values for the WHO core drug use indicators for all 
regions of the world due to differences in disease patterns, researchers have used different 
methods to arrive at reference values.  In Nigeria, local reference values for the WHO core 
prescribing indicators were computed using survey-derived morbidity data and locally 
appropriate treatment guidelines developed by a panel of health care providers. They suggested 
the following: average number of drugs per encounter (1.6-1.8); percentage encounters with 
injections (10.1%-17.0%); and with antibiotics (20.0%-25.4%); percentages of drugs prescribed 
by generic name and those prescribed from the essential drug list were assigned 100.0% each 
(Isah et al., 2001).   
 
2.3.1 Polypharmacy  
Polypharmacy involves the use of too many medicines per patient. It is generally a common 
problem in medical practice but especially in geriatric and psychiatric care where prevalence 
may be as high as 39.5% (Bregnhoj et al., 2007, Junius-Walker et al., 2006). Some authors have 
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differentiated between appropriate polypharmacy and inappropriate polypharmacy noting that 
polypharmacy may be appropriate when patients correctly receive multiple drug therapy for their 
multiple co-existing medical problems (Milton and Jackson, 2007, Aronson, 2004). However, 
inappropriate polypharmacy may result in several serious consequences such as non-compliance 
with medications, drug interactions, adverse drug reactions and waste of resources. Several drug 
studies in Nigeria have reported the problem of polypharmacy.  For example, studies done in a 
military hospital in Lagos (Adebayo and Hussain, 2009), public hospitals in Lagos (Chuckwuani 
et al., 2002 ) and Ilorin (Akande and Ologe, 2007) found an average number of drugs per 
prescription to be 3.0, 3.16 and 3.99 respectively. A comparative study of drug use patterns in 
PHC facilities on the basis of the operational Bamako Initiative (BI) drug revolving fund 
programme revealed an average of 5.3 drugs per prescription in facilities operating the drug 
revolving fund, in contrast to 2.1 in facilities not operating the programme. Studies in primary 
healthcare facilities from other parts of Africa (Nsimba et al., 2004, Desta et al., 1997) and Asia 
(Bhartiy et al., 2008, Guyon et al., 1994, Hafeez et al., 2004, De Costa et al., 2008) all reported 
average drug prescription per patient of more than 2.5. In a more comprehensive study involving 
twelve developing countries, an average number of drugs ranging from 1.3 to 2.2 was reported in 
ten out of twelve developing countries, but with Nigeria and Indonesia having values of 3.8 and 
3.3 respectively (Hogerzeil et al., 1993). 
 
2.3.2 Irrational use of anti-microbial drugs  
Antimicrobials are a group of drugs that are often used irrationally. Among the various 
antimicrobial drugs, misuse of antibiotics is particularly prevalent and has been reported in 
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several studies. Inappropriate or overuse of antibiotics is especially common in developing 
countries where antibiotics may be prescribed by any clinician and purchased without 
prescription (Thamlikitkul et al., 1998). Ochoa et al (2009) observed that due to unregulated 
antibiotic use in Lima Peru, antimicrobial drug resistance in E. coli was associated with a high 
frequency of antibiotic use for diarrhea in a cohort study of infants (Ochoa et al., 2009). 
Irrational use of antibiotics may take several forms: antibiotics may be given for illnesses for 
which they are not indicated, especially in many viral infections which may not warrant the use 
of antibiotics; broad-spectrum antibiotics may be overused in the empiric treatment of common 
infections; and intravenous antibiotics may be prescribed by healthcare providers when oral 
agents would have been sufficient. Even when the correct antibiotic choice is made, 
inappropriate antibiotic dosage, schedule or duration of treatment can threaten patient safety as 
well as increasing the risk of resistance (Kisuule et al., 2008).   
 
The consequences of inappropriate use of antimicrobials are far more serious and severe 
compared with other groups of drugs.  Like other drugs, overuse of antimicrobials may result in 
sub-optimal patient care, increased morbidity and mortality due to side effects, as well as 
wastage of financial resources, but more importantly, antimicrobial misuse may induce 
resistance of infectious organisms to these antimicrobials (Awad et al., 2006). In Ghana for 
example, 80% of patients attending government health facilities in Wassa district were 
prescribed an antibiotic (Bosu and Ofori-Adjei, 2000). Several studies have reported a consistent 
antibiotic use rate exceeding 50% in Nigeria. In a 2002 baseline survey carried out to assess the 
pharmaceutical sector in Nigeria, the report showed that 59% of patients were prescribed 
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antibiotics (FMOH, 2002). Similarly, a comparative study of prescribing practices between 
private and public health care facilities in Southern Nigeria revealed that 55% of prescriptions 
from private facilities included at least one antibiotic, while those from public facilities had 75% 
(Erah et al., 2003). Other studies in secondary health facilities in Nigeria have reported similar 
findings (Chuckwuani et al., 2002 , Nwolisa et al., 2006 , Olayemi et al., 2006). In addition, 
inadequate dose and duration of treatment have also been documented leading to the 
development of resistant strains of micro-organisms (Siddiqi et al., 2002). This is particularly 
important in diseases such as malaria and tuberculosis where inadequate or inappropriate use of 
antimicrobials have been reported to contribute greatly to evolution of resistant strains which 
have significant public health consequences (Wongsrichanalai et al., 2010). 
 
2.3.3 Irrational use of injections  
Irrational use of injections involves overuse of injections when oral formulations would be more 
appropriate. This practice has been identified as a serious public health problem in several drug 
studies from developing and transitional countries, with some documenting values as high as 
39.3% (Hauri et al., 2004, Janjua et al., 2005, Awad and Himad, 2006, Yvan et al., 2003). In 
addition to its irrational use, injection use in these regions is usually accompanied with reuse of 
injection equipment without adequate sterilization (Yvan et al., 2003). Reuse of injection 
equipment has been documented to be associated with increased transmission of blood borne 
infections such as hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunno-
deficiency virus (HIV) infections (Janjua et al., 2005, Simonsen et al., 1999).   
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In Nigeria, several studies have reported injection use in the 40-70% range (Odusanya, 2006). 
The baseline survey of the Nigerian pharmaceutical sector documented a mean injection 
prescription rate of 55%, while values between 10.8% and 40.6% were reported by other 
researchers (Ibrahim, 2004, Akande and Ologe, 2007).  Studies from other parts of West and 
Central Africa reported a similarly high injection prescription rates (Massele and Mwaluko, 1994 
, Bosu and Ofori-Adjei, 2000, Nsimba, 2006 ). All these may result in increased transmission of 
blood borne infections such as HIV and hepatitis, in addition to adverse drug reactions. 
 
2.3.4 Rational drug use and generic prescribing 
Generic prescribing is the practice of prescribing using the non-proprietary title for a 
pharmaceutical preparation. Drug prescribing using generic names has been identified to be an 
indicator of good prescribing practice.  The practice allows for the flexibility of dispensing any 
suitable generic drug rather than a particular brand of the drug. Generic prescribing can minimize 
the cost of purchasing drugs because cheaper alternatives can be prescribed. Apart from saving 
cost, it also ensures the availability of a wider range of alternative preparations that may prevent 
delays in drug dispensing. Generic products are almost always cheaper and more available than 
branded products. The practice of generic prescribing also reduces confusion as only one name 
for a drug is used instead of several branded names. However in many developing countries, 
there is a low rate of generic prescribing among healthcare providers. Generic prescribing of 
10.2% was documented among primary healthcare providers in Bahrain (Otoom et al., 2010). 
Bhartiy et al (2008) found that generic prescribing among primary healthcare providers in 
Madhya Pradesh India was 48.5%. Similarly, situations whereby the percentage of drugs 
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prescribed in generic is less than 50% have been documented in many parts of developing 
countries (De Costa et al., 2008, Pavin et al., 2003 Feb, Santos and Nitrini, 2004 May). In 
contrast, generic prescription rates of 99.8% and 87% were described among primary healthcare 
workers in Cambodia and Tanzania (Chareonkul et al., 2002, Nsimba, 2006 ). In Nigeria, most 
drug studies that looked at generic prescribing also documented low practices among healthcare 
providers. Adebayo and Hussain (2009)  documented 43.8% of drugs prescribed in generic while 
Akande and Ologe (2007) Olayemi et al (2006)  reported 43% and 50% respectively (Adebayo 
and Hussain, 2009, Akande and Ologe, 2007, Odusanya, 2006). 
 
2.3.5 Rational drug use and the Essential Drug (Medicine) List 
Essential Medicines are defined as those medicines that satisfy the priority health care needs of 
the population and which need to be available at all times in adequate amounts and in appropriate 
dosage forms at all levels of the health care delivery system of the country (Kar et al., 2010).  
The adoption of an essential medicine list is a key strategy for achieving one of the goals of the 
national drug policy which is to increase availability of essential drugs in the country (FMOH, 
2003). The use of an essential medicine list makes medicine management easier in many ways. 
Procurement, storage and distribution are easier if fewer items are involved. Furthermore, 
prescribing and dispensing also become simpler for professionals as they would need to be 
familiar with few items. 
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2.4 Factors influencing drug prescribing practices of healthcare providers  
Many factors have been identified as influencing drug use and prescribing practices of healthcare 
providers. Conventionally these factors have been divided into three broad groups: health system 
related factors, healthcare provider factors, and patient factors. Health system related factors 
include the organization and processes of healthcare delivery system, which may include drug 
policy initiatives that determine availability or restriction of prescription drugs in health facilities 
and regulation of professional practice.  Aggressive promotion and marketing of drugs by the 
pharmaceutical industries and high prevalence of fake and adulterated drugs in the community 
are also system related factors that may influence providers prescribing practices (Spurling et al., 
2010, Vancelik et al., 2007, Erah et al., 2003). Health provider factors include knowledge, 
training and skills of the provider, access to objective independent information about drugs, 
opportunities for continuing medical education, especially on drug use, incentives and 
remuneration of healthcare providers (WHO, 2002). Patient factors such as socio-economic 
factors, their perception of their illness and expectations from healthcare providers, educational 
level and cultural backgrounds have also been identified as factors that influence patterns of drug 
prescribing by health workers (Boonstra et al., 2002, Kotwani et al., 2010, Ljungberg et al., 
2007, Tan et al., 2009). These factors may operate singly or in combination in influencing the 
patterns of drug use by healthcare providers in health facilities.   
 
For example, a cross sectional exploratory study of factors influencing prescribing practices 
among general practitioners in primary health centres in Turkey found that the majority (73.7%) 
consulted pharmaceutical guides from pharmaceutical companies in cases of problems with drug 
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prescribing (Vancelik et al., 2007). In this study other self reported factors found to be 
statistically significant in influencing prescribing behavior included participation in training 
activities organized by drug companies, promotional activities by sales representatives, heavy 
daily patient load and years of practice. In a similar qualitative study among doctors at the 
secondary level of care in Sweden, it was reported that patient-specific factors and cost were 
important considerations for  healthcare providers when prescribing (Ljungberg et al., 2007). 
Other factors that influenced the prescribing habits of these doctors included written information 
sources, advertisements, personal practice, information from colleagues and the drug use 
tradition in the health facility. Tan et al‘s qualitative study among family physicians in China 
using focus group discussions indicated that medical training and acquisition of asthma-related 
information and updates were important considerations that influenced their drug prescribing 
practices for their asthmatic patients. In addition, cost of drugs and treatment, uncertainty of 
disease diagnosis, concern about drug side effects as well as patients‘ beliefs and their 
perceptions of the disease and treatment were significant considerations for the family physicians 
(Tan et al., 2009). In Nigeria, Erah et al identified patient factors (demand, culture, attitude and 
socio-economic status), prescriber factors (pre-qualification training, in-service education, work 
load and feedback from patient responses), drug factors (availability and cost) and the influence 
of industry as important influences on healthcare prescribing practices (Erah et al., 2003).  
 
A major limitation of most drug use studies in Nigeria is that they have focused on prescribing 
behavior of health workers working in secondary or tertiary health facilities. These studies, and 
the few that assessed prescribing practices at the PHC level, failed to explore the factors that may 
be responsible for the identified pattern of drug use. Thus, there is a need to conduct drug use 
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studies at PHC level that both measure the magnitude and pattern of irrational drug use, and also 
identify the reasons that may influence the observed patterns of drug use.  Information from 
these studies would assist immensely in designing evidence-based strategies to address the 
problem of irrational drug use at the PHC level.  
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CHAPTER 3 
METHODOLOGY 
3.1 Study design  
The study was a descriptive cross sectional study which assessed the level of knowledge of 
rational drug use, drug prescribing practices and factors that influenced rational drug use among 
primary healthcare providers in Zaria LGA, Northwestern Nigeria. The WHO standardized 
methodology, tools and indicators were adapted for use in the study (WHO, 1993). A cross-
sectional descriptive study design was chosen and considered the most appropriate design to use 
for this study because the study was a preliminary study into the problem of rational drug use in 
the North-western part of the country. The use of this design assisted in gathering preliminary 
information from which hypotheses could be generated about prescribing practices of health 
providers.  
 
3.2 Study setting   
Zaria Local Government Area (LGA) is located in Kaduna state, Northwestern Nigeria. It is an 
urban LGA with an estimated population of 408,198 according to the 2006 census (NPC, 2006). 
The predominant ethnic group is Hausa/Fulani, and the majority of the inhabitants are Muslims 
working as civil servants or farmers. The health department of the LGA consists of the following 
units: Maternal and Child Health/Family Planning, Medical, Disease Control, National Program 
on Immunization, Essential Drug Supply, and Monitoring and Evaluation units. There are 33 
public PHC facilities divided among the 13 wards that make up the local government. Of these, 
seven are primary health centres while the rest are basic health centres. Both types of health 
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centres provide curative services for simple and acute ailments in addition to preventive and 
promotive services. However, primary health centres have in addition a limited number of beds 
for admission of acute cases. Basic health centres usually have fewer staff compared to primary 
health centres.  The health department of the LGA has a total of 354 healthcare providers at its 
public PHC facilities. This comprises 192 community health assistants (Community Health 
Officer (CHO) and Community Health Extension Workers (CHEWs)), 33 nurses/midwives, 106 
environmental health officers, 13 pharmacy technicians and 10 laboratory technicians. In 
addition, medical officers, when available, work at the health facilities and provide both medical 
and supervisory functions. In facilities with no medical officers, the CHO has both supervisory 
and medical responsibilities. The CHEWS, on the other hand are responsible for preventive and 
promotive health activities in the LGA. In many primary healthcare facilities in most LGAs 
across the northern parts of Nigeria, there are no medical officers, hence the nurses/midwives, 
CHOs and CHEWs are responsible for prescribing drugs. Complicated cases that cannot be 
managed at this level are referred to secondary healthcare facilities. 
 
3.3 Study population  
The study population included all 33 public PHC facilities in the LGA (seven primary health 
centres and 26 basic health centres) and patient encounters were drawn from these facilities. In 
addition, the 225 prescribing healthcare providers in these health facilities were included in the 
study. The PHC facilities were the primary sampling unit. 
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3.4 Sample size determination 
3.4.1 Health facilities and Patient encounters  
The sample size for this study was calculated using methods recommended by the WHO for drug 
use indicator studies. According to this method, the goal of a drug use study should be to 
estimate percentage indicators that summarize values for the sample as a whole with a 95% 
confidence interval and a precision level of ± 7.5% (WHO, 1993). Based on this, at least 600 
patient encounters were included in the study, with 30 each selected from the 20 selected health 
facilities. 
 
3.4.2 Health providers 
All 163 prescribing health providers at the 20 sampled health facilities were included in the 
study.  
 
3.5 Sampling technique  
A multistage sampling technique involving two stages was used in this study. The first stage 
involved sampling the health facilities, which were the primary sampling unit. Twenty health 
facilities were sampled through systematic random sampling from a sampling frame of 33 public 
health facilities in the study area. The health facilities were stratified according to the two types 
and their capacity in service delivery i.e seven primary health centres and 26 basic health centres. 
Twenty facilities were selected proportional to size according to this classification resulting in 
four primary health centres and 16 basic health centres being selected. A sampling interval was 
calculated by dividing the total number of health facilities in each category by total number of 
required sample. Thereafter, a number was randomly chosen by ballot between 1 and the 
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sampling interval to pick the first health facility. Subsequently, the sampling interval was added 
to the previous number until 20 health facilities were selected.  
The second stage involved sampling of 30 patient encounters (secondary sampling units). In each 
sampled health facility, patient encounters were selected retrospectively over a period of one 
year (January 2010- December 2010) using stratified random sampling. The total number of 
prescriptions were ascertained for the whole year and arranged chronologically. The sampling 
interval was computed by dividing the total number of prescription for the study period (January 
2010 - December 2010) in each health facility by 30. A number was chosen at random between 1 
and the sampling interval using balloting method to pick the first prescription. Other 
prescriptions were selected by adding the sampling interval to the previous figure. 
 
3.6 Data collection  
Three data collection tools were used in this study: an adapted WHO‘s Detailed Indicator 
Encounter Form, Prescribing Indicator Form and a Structured Self administered Questionnaire 
designed by the researcher (Appendix I), each taking an average of 20, 15, and 10 minutes to be 
filled respectively. 
Tool 1: Detailed Indicator Encounter Form. This was administered at the record department of 
the selected health facility. From the selected prescriptions, information on patients‘ 
identification including age and sex, health problems as well as names and strength of the 
prescribed drugs were collected.  
Tool 2: Prescribing Indicator Form. This was used to collate the information from the 30 
patient encounters entered in the Detailed Indicator Encounter Form from each health facility.  
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Tool 3: Structured Self administered Questionnaire. This was administered to the prescribing 
healthcare providers in the selected health facilities. This was used to collect information on 
knowledge about rational drug use, and practices of rational prescribing practices among primary 
healthcare provider using the last prescription issued by the health provider prior to the 
interview.  
 
The data were collected by the researcher with the assistance of three trained research assistants. 
The research assistants were recruited from the resident doctors at the Department of Community 
Medicine, Ahmadu Bello University Teaching Hospital, Zaria. They were considered to be 
suitable as research assistants for the study because they had background knowledge of 
pharmacology, and were familiar with pharmaceutical terms which were necessary to be able to 
reliably extract information from records and record them accurately. Before commencing the 
data collection a two day training session was conducted for the research assistants on the use of 
the study instruments as well as the methodology employed in the study. During the training, 
didactic presentations on the scope of the study, concepts of rational drug use with emphasis on 
the key indicators to be assessed, and practice sessions on sampling, data extraction and entry 
using the appropriate forms were conducted. All data collection tools were pretested in two of 
the health facilities (one primary health centre and one basic health centre) not selected for the 
study and appropriate revisions and corrections made before the commencement of data 
collection. For example, in the sections on attitude of healthcare providers to rational prescribing, 
some items were reworded to remove ambiguity in interpretation. Similarly, related questions 
were regrouped in the section on factors influencing rational prescribing to allow for easier flow 
of the questionnaire.   
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3.7 Data management and analysis  
The data collection took place between 4
th
 January and 28
th
 February 2011.   All forms were 
checked for accuracy and completeness before leaving the health facility. Data were 
subsequently entered into the Statistical Package for Social Sciences (SPSS Version 17) software 
and summarized using means and standard deviations. Presentation of data was done using 
contingency tables and chi square test was used to test for relationship between variables with 
statistical significance taken at p < 0.05. Analysis of the drug use indicators was done based on 
selected WHO‘s standard indicators for assessing drug prescription patterns. This included the 
following: average number of drugs per prescription/encounter; percentage of encounters with 
antibiotic prescribed; percentage of encounters with injections prescribed; percentage of drugs 
prescribed by generic name; and percentage of drugs prescribed from essential drug list. In 
evaluating the levels of knowledge, a total of 15 items were scored (see Appendix 1 tool III 
section B, Questions 1-5 [Options in questions 3 and 4 were scored individually]) with every 
correctly answered question allocated 1 mark while incorrectly answered question attracted no 
mark. Aggregate scores were computed for each. The aggregate scores were further categorized 
into poor (0-6 correctly answered questions) and good knowledge (7-15 correctly answered 
questions). Bivariate analysis was conducted by cross tabulating practices with factors related to 
rational drug use.   
 
3.8 Validity and Reliability  
Validity and reliability were achieved through standardization of all tools for data collection. 
Very importantly, the tools were adapted WHO drug use instruments which have been 
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standardized and used extensively in drug use studies across the world. The tools were pre-tested 
in similar settings prior to commencing the data collection for this study and several adjustments 
were made to improve clarity and flow of questions. The recruitment of research assistants was 
also carefully carried out as resident doctors with adequate knowledge of pharmaceutical terms 
were selected to ensure validity and reliability of collected data. In addition, the process of data 
collection was standardized by training the research assistants on the methodology of the study 
and use of the data collection tools before the commencement of the study. This ensured 
uniformity in the process of data collection. Spot checks of forms was carried out in the field by 
the researcher such that errors were promptly detected and corrections effected by the research 
assistants before leaving the field. Questionnaires were also checked for accuracy and 
completeness by the researcher before entering it into computer statistical software (SPSS 
Version 17).  After the completion of data entry, data cleaning was carried out and accuracy 
ensured before final data analysis. 
 
3.9 Limitations  
A major limitation of this type of study is availability of complete data on the patient records 
which may reduce the validity of the data collected (WHO, 1993). In this study, however, 
assessment of the availability and completeness of data in health facilities prior to 
commencement of study was found to be adequate. During the study, retrieving patients‘ cards 
was easy as they were kept in the medical record units of the health facilities and details of 
prescribed drugs was found to be adequate and easy to extract as prescribed medications were 
recorded on the patients‘ cards.  
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3.10 Ethical considerations  
Ethical clearance was obtained from the Research Ethics Committee of the University of the 
Western Cape and the ethical committee of Kaduna State Ministry of Health, Nigeria before 
embarking on the study. Permission was also sought from the local government chairman and 
management of the health facilities that were used for the study. The objectives and the scope of 
the study were duly explained to them (Appendix II). Prior to the administration of the 
questionnaires, written informed consent was obtained from sampled health providers and they 
were assured of the confidentiality of the information that was collected (Appendix III). All 
participants were assured of the voluntary nature of participating in the study and they were 
further informed that they might withdraw their participation at any period during the study 
without any consequences. Information collected from the study was kept in lockers in the 
custody of the researcher and the computer used for data entry was password protected to ensure 
its safety and confidentiality. At the end of the study, a meeting will be organized to disseminate 
the results of the study to healthcare providers, managers of the health facilities as well as 
officials from the health department of the local government. 
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CHAPTER 4 
RESULTS 
4.1 Introduction  
This chapter is divided into four sections and it presents the findings in line with the study 
objectives. The distribution and socio-demographic characteristics of healthcare providers 
interviewed is presented first and followed by their knowledge and attitude to rational drug use. 
The findings on prescribing behavior of healthcare providers are presented thereafter, with 
factors affecting healthcare providers‘ rational prescribing following.  
Twenty health facilities were included in the study, 600 patient prescriptions were reviewed and 
a total of 163 healthcare providers were interviewed. In each health facility, a list of all 
prescribing staff was obtained and each provider interviewed and those that were not present on 
the day of the survey were followed up and subsequently interviewed. Out of the 163 retrieved 
questionnaires, only 158 questionnaires were suitable for analysis as five were discarded because 
of incomplete entries, giving a response rate of 96.9%.  
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4.2 Distribution and socio-demographic characteristics of healthcare providers 
Table 1: Distribution of healthcare providers by facility (N=158) 
Facility  Number (%) of 
healthcare providers 
Facility Number (%) of 
healthcare providers  
A   8    (5.1) K 7   (4.4) 
B* 12    (7.6) L 7   (4.4) 
C* 15    (9.5) M 6   (3.8) 
D   9    (5.7) N 5   (3.2) 
E* 10    (6.3) O 7   (4.4) 
F   6    (3.8) P 4   (2.5) 
G* 13    (8.2) Q 8   (5.1) 
H   6    (3.8) R 7   (4.4) 
I   8    (5.1) S 8   (5.1) 
J   5    (3.2) T 7   (4.4) 
*Primary health centre 
The distribution of the healthcare providers across the 20 health facilities is as shown in table 1. 
Health facilities C, G and B, which are three of the primary health centres, had the largest 
number of healthcare providers and accounted for 9.5%, 8.2% and 7.6% of all interviewed 
healthcare providers respectively. 
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Table 2: Socio-demographic characteristics of healthcare providers (N=158)  
Age group (yrs) Frequency (n) Percentage (%) 
20-24 4 2.5 
25-29 32 20.3 
30-34 14 8.9 
35-39 40 25.3 
40-44 35 22.2 
45-49 18 11.4 
50- 54 15 9.5 
Sex    
Male  53 32.9 
Female  105 67.1 
Marital status   
Single  18 11.4 
Married  137 86.7 
Divorced/ Separated 3 1.9 
Tribe    
Hausa  131 82.9 
Fulani 17 10.8 
Yoruba 4 2.5 
Others 6 3.8 
Religion    
Islam 150 94.9 
Christianity  8 5.1 
Professional status   
Nurse/Midwife 20 12.7 
CHO 18 11.4 
SCHEW 96 60.8 
JCHEW 24 15.2 
Duration of service (yrs)   
1-5 50 31.6 
6-10 34 21.5 
11-15 40 25.3  
16-20 8 5.1 
21-25 14 8.9 
26-30 12 7.6 
 
The frequency distribution of the socio-demographic characteristics of health providers is as 
shown in Table 2. Of the 158 healthcare providers, the age group with the highest frequency was 
35-39 years, accounting for 25.3%. This was followed by those within the age group of 40-44 
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years with 22.2%. The mean age was 37.2 ± 8.1 years. Females constituted the majority (67.1%) 
of all the health care providers and the majority (86.7%) were married. The predominant ethnic 
group among the healthcare providers was Hausa which constituted 82.9% while others (3.8%) 
included Kagoro, Ebira, Kataf, Jaba ethnic groups and the majority (94.9%) were Muslims. Most 
of the healthcare providers (60.8%) were SCHEWs, while JCHEWs and nurses accounted for 
15.2% and 12.7% respectively. About a third of the healthcare providers had being in practice for 
1-5 years while another quarter had practiced for 11-15 years. The mean duration of years of 
practice was 10.7 ± 8 years. 
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4.3 Knowledge and attitude of healthcare providers to rational drug use 
4.3.1. Healthcare providers’ knowledge about Rational Drug Use 
Table 3: Healthcare providers’ knowledge of Rational Drug Use (N=158)  
Response  Frequency Percentage  
Understanding of Rational Drug Use   
Judicious use of medicines in patient care 36 22.8 
Drugs that are used in everyday practice 13 8.2 
Drugs used in treating patients 18 11.4 
Prescribing drug in a standard way 5 3.2 
Don‘t know 86 54.4 
Ability to correctly detail Rational Drug Use sequence   
Able to detail correct sequence 17 10.8 
Unable to detail correct sequence 141 89.2 
Identified components of rational prescribing*    
Choice of drugs 40 25.3 
Dosage of drug 50 31.6 
Route of administration 38 24.1 
Duration  45 28.5 
Generic prescription  42 26.5 
Number of prescribed drugs 31 19.6 
Information about drug 34 21.5 
Identified consequences of irrational drug use*   
Sub-optimal care 78 49.4 
Wastage of resources  30 19.0 
Microbial resistance  22 13.9 
Adverse drug reactions 26 16.5 
Others  17 10.8 
*Responses with multiple options 
 
Table 4: Healthcare providers’ level of computed knowledge of Rational Drug 
Use (N=158) 
Level of computed knowledge of Rational Drug Use   
Poor  116 73.4 
Good 42 26.6 
 
Knowledge of Rational Drug Use is an important determinant of prescribing practices of 
healthcare providers, however, as shown in table 3, more than half (54.4%) of the healthcare 
providers said they did not know what RDU was, with less than a quarter (22.8%) responding 
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correctly that it was ‗judicious use of medicine in patient care‘. Only a few (10.8%) could detail 
the correct sequence of rational drug prescribing. Regarding identification of the components of 
rational prescribing, only about half of healthcare providers could correctly identify each of the 
components listed, with only 31.6% and 28.5% being able to identify dosage and duration of 
treatment as components respectively.  Sub-optimal care, which accounted for 49.4%, was the 
highest identified consequence of irrational use of drugs, while less than a quarter identified 
other listed consequences.  From the composite score {computed from 15 items with each 
correctly identified item awarded one mark and total score further categorized into good(≥7) and 
poor(<7)}of on knowledge of RDU, the majority (73.4%) of respondents had a poor level of 
knowledge of rational drug use (Table 4). Questions used in computing composite score included 
providers understanding of rational drug use, ability to detail sequence of rational drug use, 
identify components of rational prescribing and consequences of irrational prescribing.  
 
 
 
Figure 1: Healthcare providers’ awareness of Essential Drug List  
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Figure 1 shows that just over half (58%) of healthcare providers were not aware of the Essential 
Drug List. 
 
Table 5: Health providers’ primary source of information and attendance at Rational Drug 
Use training (N=158) 
Source of information Frequency  Percentage  
Advertisement by Drug companies 22 13.9 
Standing order* 80 50.6 
Drug formulary 4 2.5 
Drug leaflet 50 31.6 
Sales representative  2 1.3 
Awareness of National Drug Formulary   
Aware 6 6.8 
Not Aware 152 96.2 
Attendance at Rational Drug Use training in the 
last one year 
  
Attended  17 10.8 
Did not attend 148 89.2 
Total  158 100 
*Treatment Guidelines for CHO and CHEWS 
 
Table 5 shows that about half (50.6%) of healthcare providers indicated that they relied on 
Standing Order for information about prescription drugs while another 31.6% and 13.9% relied 
on drug leaflets and advertisement from drug companies respectively. On awareness of the 
National Drug Formulary, the majority (96.2%) indicated they were not aware. The majority of 
healthcare providers (89.2%) also indicated they had not received training in RDU in the 
previous year.  
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Table 6: Cross tabulation of healthcare providers’ level of knowledge of Rational Drug Use 
and professional status, duration of service and having received training in the past year 
(N=158) 
 
Variable  Level of knowledge 
Professional status Poor  Good  
Nurse /midwife 16 4 
CHO 4 10 
SCHEW 74 26 
JCHEW 22 2 
Total 116 42 
Chi square=18.98 Df=3 P=0.00001 
   
Duration of service (years)    
1-5 43 7 
6-10 20 14 
>10 53 21 
Total  116 42 
Chi square=7.88 Df=2 P=0.019 
   
Rational Drug Use training 
in the past year 
  
Yes  5 12 
No  111 30 
Total  116 42 
Chi square=18.9 Df=1 P=0.00001 
 
 
Table 6 shows the relationship between healthcare providers‘ level of knowledge of RDU and 
professional status, duration of service and training.  A statistically significant difference was 
found between the level of knowledge and professional status (p< 0.05). In this study it was 
found that whilst the majority of nurse/midwives, SCHEWs and JSCHEWs interviewed were 
classified as having poor knowledge 16 (80%), 74 (74%) and 22 (91.7%) respectively, the 
majority of CHOs, 10 (71.4%) were classified as having good knowledge.  
In the same table, while only a little more than half 20 (58.8%) of mid-career (6-10years) 
healthcare providers were classified as having poor knowledge of RDU the study found that the 
 
 
 
 
36 
 
majority 43(86%) and 53(71.6%) of providers in their mid and late career respectively were 
similarly classified as having poor knowledge.   
Only a small proportion, 17(10.8%), of healthcare providers had received training in RDU in the 
past year. However of those who did, the majority 12 (70.6%) were classified as having good 
knowledge of RDU as compared to only 5 (21.3%) of those that did not.  Duration of years of 
service and having received RDU training in the previous year also both show significant 
association (p<0.05) with knowledge of RDU. This means there is an association between level 
of knowledge and professional status, duration of service and training in RDU in the previous 
year. 
 
4.3.2 Healthcare providers’ attitude to Rational Drug Use 
Table 7: Healthcare providers attitude to Rational Drug Use (N=158)  
Response  SA 
(%) 
A 
(%)  
U 
 (%)  
D 
 (%) 
SD  
(%) 
Optimal patient care involves how drugs are 
prescribed for patient 
83.5 8.9 6.3 0 1.3 
A health worker may prescribe injection for 
patient if a patient demands for it 
12.5 22.8 3.1 21.1 40.5 
Antibiotics should be prescribed for all cases 
of URTI 
60.8 15.5 8.9 3.8 11.0 
It does not matter whether a health provider 
prescribe in generic or trade name 
34.2 11.4 15.2 12.7 26.6 
More drugs can be prescribed for patients to 
make him happy even if he does not need all 
the drugs 
8.2 6.3 5.0 31.7 48.8 
Drugs that are not in EDL may be prescribed 
for patients so far it is effective 
15.3 10.1 52.3 6.1 16.2 
*SA= Strongly Agree; A=Agree; U=Undecided; D= Disagree; SD=Strongly Disagree 
 
 
The attitude of healthcare providers to RDU is presented in table 7. The majority (83%) strongly 
agreed (SA) that optimal patient care involved how drugs were prescribed for patients with 6.3% 
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and 1.3% of respondents undecided (U) and strongly disagreeing (SD) respectively. Respondents 
who strongly agreed that a healthcare provider might prescribe injections on patients‘ demand 
accounted for 12.5% while 22.8% agreed (A).  The majority (60.8% strongly agree and 15.5% 
agree) indicated that antibiotics should be prescribed for all cases of Upper Respiratory Tract 
Infection (URTI). Almost half felt that it did not matter whether a health provider prescribed in 
generic or trade name and this included 34.2% who Strongly Agreed, 11.4% who Agreed and 
15.2% who were Undecided. On whether more drugs could be prescribed to meet patient demand 
even if the patient did not need all of the drugs, the majority of healthcare providers‘ strongly 
disagreed (48.8%) while 31.7% just disagreed (D). Almost half (52.3%) of the respondents were 
undecided whether an effective drug that is not in EDL should be prescribed for patients. 
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4.4 Prescribing practices among healthcare providers 
 
The prescribing practices of the healthcare providers were assessed using both retrospective 
audits of patient prescriptions as well as the last prescriptions by healthcare providers on the day 
of the survey. A total of 600 patient encounters, 30 from each of the 20 sampled health facilities 
were reviewed for the retrospective audit while 158 healthcare provider prescriptions (one 
prescription per healthcare provider included in the study) were also reviewed. The WHO‘s core 
rational drug use indicators were subsequently computed to assess prescribing practices.  
 
Table 8: Distribution of number of drugs per prescription by retrospective review and 
survey 
 
Number of drugs per 
prescription 
Retrospective review of 
patient encounters  
(Jan-Dec 2010) N=600 
Surveyed healthcare 
providers prescriptions  
(N=158) 
Frequency Percentage Frequency Percentage  
None  2 0.3 0 0 
1-2 50 8.3 10 6.3 
3-4 480 80.0 118 74.7 
5-6 61 10.2 27 17.1 
7 and above 7 1.2 3 1.9 
Mean                                           3.7±0.9  3.9±1.2  
 
 
Table 8 shows the majority of prescriptions were in 3-4 drugs/prescription category, accounting 
for 80.0% (mean=3.9±1.2) for retrospective review and 74.7% (mean=3.7±0.9) for surveyed 
prescriptions from healthcare providers respectively. The table also reflects that 0.3% and 0% of 
patient encounters did not receive any medications in the retrospective review and the survey, in 
contrast to 1.2% and 1.9% of patients‘ encounters who received 7 or more drugs respectively. 
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Figure 2: Selected prescribing indicators by retrospective review and survey (N=158) 
 
Figure 2 shows that the percentage of prescriptions written in generic names was just above half 
and one thirds for the retrospective review and the survey respectively. In more than half of the 
patient encounters an antibiotic was prescribed, 63.3% and 82.9% of the retrospective review and 
surveyed healthcare providers‘ prescriptions respectively. The injection use, as reflected by 
percentage of patient encounters with an injection, was a little more in the surveyed healthcare 
providers than the retrospective review accounting for 12% and 9.5% respectively. Both the 
survey and the retrospective review of patient encounters found that more than two thirds of all 
drugs prescribed were on the EDL. 
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Table 9: Health providers’ access and use of Essential Drugs List (N=158) 
 
Essential drug list Frequency Percentage 
Access to EDL 22 13.9 
Routinely use EDL 9 5.7 
 
Table 9 shows that only 13.9% of healthcare providers have access to the essential drug list and 
5.7% use it routinely while prescribing.  
 
4.5 Factors influencing rational drug use 
 
Table 10: Factors that influence drug prescribing practices (N=158) 
 
Factor   Drug choice Dose  Route  Duration  
 Freq % Freq  % Freq  % Freq  % 
Personal experience 16 10.2 13 8.1 17 11.0 8 5.2 
Routine practice in facility 8 5.1 12 7.6 4 2.3 4 2.3 
Available drug in facility 24 15.3 0 0 0 0.0 0 0 
Cost of drug  5 3.2 0 0 4 2.3 3 2.1 
Patient/care giver expectation 7 4.3 0 0 32 20.4 0 0.0 
Pharmaceutical guide 0 0.0 61 38.7 2 1.1 11 7.1 
Promotion by sale             
representatives 
0 0.0 0 0 0 0.0 0 0.0 
EDL 2 1.1 8 5.1 6 3.8 2 1.1 
Patient Load 0 0 0 0 0 0 0 0 
Standing order 96 60.8 64 40.5 93 59.1 130 82.2 
Total  158 100 158 100 158 100 158 100 
 
 
Table 10 shows healthcare providers response on what influenced their decisions when 
prescribing. The majority (60.8%) indicated that the Standing Order influenced their decision on 
which drug to prescribe while 15.3% and 10.2% indicated drug availability and personal 
experience respectively. Forty percent of healthcare providers also indicated being influenced by 
the Standing Order and another third (38.7%) pharmaceutical guide as a major consideration for 
dosage of prescribed drugs. Almost one third of healthcare providers said they would consider 
patient/care givers‘ expectations in deciding the route of administration of drugs, while the 
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majority indicated they would be influenced by the Standing Order (59.1%). The majority of 
healthcare providers (82.2%) indicated the Standing Order as the main consideration for deciding 
the duration of treatment. The study found that the Standing Order was a major influence in 
decisions on choice of drug, route of administration, and duration of treatment for the health 
providers.  
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CHAPTER FIVE 
DISCUSSION 
5.1 Introduction 
Irrational drug use poses an important public health problem globally, especially in developing 
countries, and rational prescribing among healthcare providers constitutes an important 
component of rational drug use. This study aimed at assessing rational drug use, with a focus on 
rational prescribing, among public primary health care providers in Zaria Local Government 
Area (LGA), Nigeria. It is hoped that the findings will provide an understanding of the 
prescribing practices of healthcare providers and the factors influencing them, and that these will 
be used to make evidence-based recommendations towards improving rational use of drugs 
among healthcare providers. Overall the results from this study were comparable to published 
literature from developing countries in areas like polypharmacy, use of antibiotics and injections 
and generic prescribing practices, but differed in other areas such as source of drug information 
and factors affecting rational use of drugs. This chapter commences with the profile of the 
healthcare providers studied and is followed by discussing healthcare providers‘ practice of 
rational drug use, their knowledge and attitude, and concludes with the factors affecting rational 
prescribing. 
 
5.2 Profile of healthcare providers 
A good understanding of healthcare providers‘ characteristics are likely to give insights into their 
prescribing practices, as it has been reported in the literature that prescribing practices are 
influenced by professional status, years of experience, age and sex (Ljungberg et al., 2007, 
Kotwani et al., 2010). In this study, prescribing staff at the health facilities comprised 
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nurses/midwives and community health assistants only and no physicians were identified at any 
of the selected facilities (Table 2). Both Bolarinwa et al (2011) and an assessment of the 
Nigerian pharmaceutical sector conducted several years ago reported a similar findings with 
community health assistants (CHO and CHEWS) and nurses as the health professionals 
comprising the majority of prescribing staff at PHC facilities in Nigeria (Bolarinwa et al., 2011, 
FMOH, 2002). However, other studies at the primary level of care reported that trained 
physicians formed a significant proportion of prescribing staff at primary health care facilities 
(al-Nasser, 1991, Bregnhoj et al., 2007).  
 
Prescribing behavior has been linked to the status and level of training of prescribing staff  
(Ofori-Adjei and Arhin, 1996), which is understandable as the training of the various cadres of 
healthcare providers differs in content, depth and duration. At one end, the training of general 
physicians usually lasts a minimum of six years at a university and is broader in scope and depth 
than the other cadres of healthcare providers, usually incorporating basic principles of 
pharmacology and dispensing. At the other extreme, the community health extension workers, 
who constitute the lowest in the hierarchy of prescribing health staff, spend two (JCHEW) or 
four (SCHEW) years at a School of Health Technology with curricula mainly focusing on 
preventive and promotive services. However, with the dearth of trained providers at the primary 
health care level, the lower cadre healthcare providers such as the CHEWS have taken up clinical 
responsibilities including drug prescribing at this level.  The lower cadre health professionals 
also often times have less access to opportunities for more training and continuous medical 
education that may improve their practice. It is also worthy of note that even though the majority 
of these health professionals had practiced for more than five years in the service of the health 
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department of the LGA, regular training in rational drug use was not a routine practice as only 
10.8% indicated they had attended training on rational drug use in the past year (Table 5).  This 
further implies that healthcare providers have limited or no access to training on rational 
prescribing and therefore lack the opportunity to update and improve their skills about rational 
prescribing. 
 
The age distribution of healthcare providers‘ in this study revealed that the majority were in the 
35-39 years and 40-44 years age groups. The mean age of 37±8.1 years is comparable to 39±8 
years in a similar study which assessed knowledge and attitude of primary healthcare workers on 
safe injections in the North-central states of Nigeria (Bolarinwa et al., 2011). Other studies from 
Nigeria also documented a relatively older population of healthcare providers (Musa, 2005). The 
predominance of a relatively older workforce may be as the result of upward migration of 
younger lower cadre healthcare providers along the professional ladder. Healthcare providers 
were also found to be predominantly females, and again this finding correlates with other studies 
in Nigeria which found a preponderance of female providers among healthcare providers at the 
primary level of healthcare (Uzochukwu et al., 2011, Bolarinwa et al., 2011). In Nigeria and 
many developing countries, the female gender is associated with nursing and many other nursing 
related professions. Hausa ethnic group, who are predominantly of the Islam faith, constituted 
the majority. This is expected because the Northwestern region of Nigeria where the study was 
conducted is mainly populated by the Hausa Muslims.   
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5.3 Practice of rational drug use by healthcare providers 
The WHO drug use indicators were used to assess prescribing practices of healthcare providers 
in this study. Unlike many drug use studies that were limited to retrospective audit of patient 
encounters/prescriptions, this study combined both retrospective audit and evaluation of 
prescribers‘ last prescription to increase the validity of the study findings. The drug use 
indicators examined included average number of drugs per prescription, percentage of drugs 
prescribed by generic, percentage of prescriptions with antibiotic and injections, percentage of 
drugs prescribed from EDL. This study revealed that the practice of irrational use of drugs was 
prevalent in the health facilities. Poly-pharmacy was prevalent and the average number of drugs 
per prescription of 3.9 and 3.7 for retrospective review and surveyed health professionals was 
similar to findings from other researchers in Nigeria and many other developing countries 
(Nsimba et al., 2004, Nasseb and Nasser, 2005 Sep, Odusanya and Oyediran, 2004).  Hogerzeil 
et al (1993) also found an average drug per prescription of 3.8 drugs per prescription in Nigeria, 
while findings from Zimbabwe and Sudan recorded a lower value of 1.3 and 1.4 drugs per 
prescription respectively (Hogerzeil et al., 1993).  
 
The practice of prescribing using generic names has been documented as a means of improving 
accessibility and availability of drugs, including making them more affordable to patients, as 
well as making drug management easier. Whilst the WHO recommends that generic prescribing 
should be 100%, unfortunately in this study, only 60% of reviewed prescriptions and 65% of 
surveyed health providers‘ prescriptions were written generically (Figure 2). This finding was 
comparable to many other studies at the primary care level in developing countries where drugs 
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are usually not prescribed generically (Akande and Ologe, 2007, Bhartiy et al., 2008, Chareonkul 
et al., 2002).  Similar findings have also been documented among healthcare providers at both 
secondary and tertiary level of care in many developing countries (Akande and Ologe, 2007, 
Biswas et al., 2000, Chuckwuani et al., 2002 ).  
 
Worldwide, almost 50% of antibiotics are reportedly prescribed unnecessarily (WHO, 2006).  
The baseline assessment of  the pharmaceutical sector in Nigeria and the survey by the WHO 
about drug use in Nigeria documented that 59% (FMOH, 2002).  and 60% (WHO, 2006)  of 
patients received antibiotics respectively. In this present study, the percentage of prescriptions 
containing antibiotics was even much higher amounting to 68.8% and 82.9% of retrospective 
audit and surveyed health care providers respectively (Figure 2).  These findings were 
comparable to studies in developing countries where the proportion of prescriptions containing 
antibiotics was found to be as high as 60% (Bhartiy et al., 2008, Otoom et al., 2010, Cheraghali 
and Idries, 2009). Nisimba et al (2006) in a study among children under five years of age 
attending PHC facilities in Tanzania reported that  antibiotics were prescribed for conditions 
such as malaria, diarrhoeal diseases, and upper respiratory tract infections (Nsimba, 2006 ). This 
finding was similar to the attitude of healthcare providers in this study as the majority indicated 
that antibiotics should be prescribed for all cases of upper respiratory infections (Table 6). This 
unnecessary use of antibiotics could result in antibiotic resistance, in addition to sub-optimal 
patient care additional treatment costs for patients. 
 
Inappropriate use of injections is a major problem in Nigeria and in many other developing 
countries. In this study, injection use was high, with prescriptions containing injections 
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accounting for 9.5% and 12% of retrospective audit of patient encounters and surveyed 
healthcare professionals respectively (Figure 5). This figure was comparable with several other 
studies in Nigeria where injection use has been consistently above 10% (Akande and Ologe, 
2007, Olayemi et al., 2006, Adebayo and Hussain, 2009, Ibrahim, 2004).  The overuse of 
injections has important and significant consequences such as increased treatment cost and the 
likelihood of increased transmission of blood borne infections, especially HIV and hepatitis. Non 
adherence to universal precautions guidelines and reuse of needles which are common in these 
settings could further aggravate these problems.  
 
5.4 Healthcare providers and knowledge of Rational Drug Use 
The general understanding of prescribers about rational drug use in this study was poor as more 
than half of all respondents did not know the meaning of rational drug use (Table 2). This 
correlates with the fact that majority of the prescribers could also not correctly detail the 
sequence of rational drug prescribing, correctly identify the components of rational prescribing 
or consequences of irrational prescribing. This was in keeping with findings from similar studies 
which identified poor knowledge of rational drug use among prescribers in health providers in 
primary, secondary and tertiary levels of care (Adebayo and Hussain, 2009, Akande and Ologe, 
2007, Alam et al., 2006). This implies that the problem of irrational prescribing is prevalent at all 
the levels of healthcare. 
 
It was expected that an association would exist between knowledge of rational drug use and 
particularly rational prescribing and professional status of healthcare providers. This would 
probably be as a result of the differences in depth and scope of training of the various cadres of 
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healthcare providers as well as opportunities for continuous medical education. In this study, 
level of knowledge of rational drug use was found to be statistically significantly associated with 
professional status (Table 6). This is in consonance with findings from a similar study which 
noted a significant association between level of knowledge and practice of rational drug 
prescribing and the cadre of the  prescriber (Bosu and Ofori-Adjei, 2000). In this present study 
Community Health Officers had better knowledge of rational drug use than the nurse/midwives 
and the CHEWS. This is contrary to what might ordinarily be expected as Nurses/Midwives are 
of higher professional status. However, this is expected in this setting when one considers that 
the training of CHO‘s in Nigeria is specifically tailored towards medical consultation and 
prescribing using a standard treatment guideline (Standing Order) compared to that of nurses and 
CHEWS. 
 
Of paramount importance to rational prescribing is providers‘ awareness of the essential drug list 
and its availability in health facilities. Various interventions aimed at promoting rational drug use 
and improving prescribing practices of healthcare providers have focused on the availability of 
the essential drug list in health facilities. In this study, the majority of prescribers were not aware 
of an essential drug list (Figure 1). This was in contrast to another study in the country which 
documented awareness of EDL as 90.5% in a military hospital (Adebayo and Hussain, 2010). 
However, it would be expected that trained physicians, who were the subject of the latter study, 
should be more aware of EDL than other cadres because of the wider scope of their training. 
Healthcare providers‘ awareness of the National Drug formulary was even poorer. This is not 
surprising as the majority of the healthcare providers in this study depended almost exclusively 
on Standing Orders for drug prescribing. The use of Standing Orders and its influence on rational 
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drug prescribing among healthcare providers at the PHC level was quite encouraging as the 
Standing Order is a form of standard treatment guideline within which healthcare providers 
operate. Despite this however, the percentage of drugs prescribed from the Essential Drug List 
was 75.3% and 83.5% for retrospective audit and surveyed healthcare providers prescriptions 
respectively. This means that providers still prescribed some drugs outside the EDL. This was 
consistent with providers‘ attitude in which a significant proportion agreed or was undecided 
about prescribing an effective drug that was not on EDL (Table 7).  
  
Healthcare providers‘ access to accurate information about drugs is vital to rational prescribing. 
Several drug information reference documents were used by healthcare providers, including the 
National Drug Formulary, Essential Drug List and Standing Order. The National Drug 
Formulary is a compendium of drugs in the country with comprehensive information about 
dosage, forms and preparations, contraindications, side effects and interactions. The Essential 
Drug List gives information about dosage, forms and strength of essential drugs. The Standing 
Order is a form of standard treatment guideline for CHO and CHEWS detailing flow charts for 
common conditions at the PHC level. It is an algorithm which guides the PHC providers to reach 
a diagnosis and provide treatment. In this study, healthcare providers‘ source of information 
about drugs was mainly from the Standing Order, although the Standing Order does not provide 
detailed information about drugs or their side effects (Table 5). This finding was in contrast to 
other studies which indicated seeking information from colleague, the media and leaflets as the 
important sources of information about drugs (Ohlsson et al., 2005). Other sources of drug 
information listed in this study included drug leaflets and advertisements from drug companies. 
These sources of information may not however provide adequate, accurate and unbiased 
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information about drugs. However, since the Standing Order is put to good use by healthcare 
providers in diagnosis, same could be utilized in promoting rational prescribing by incorporating 
explicit drug information. 
 
5.5 Healthcare providers’ attitude to rational use of drugs 
In this study, the majority of healthcare providers admitted that optimal patient care involved 
how drugs were prescribed for the patients. Having said this however, many went on to describe 
irrational drug use practices. A significant proportion of the health workers (35.3%) also felt 
injections can be prescribed for patient on request (Table 7), a practice documented in a similar 
study (Yvan et al., 2003). Patients‘ demands and expectations have been documented as 
important factors influencing rational prescribing among healthcare providers. Similarly, the use 
of antibiotics for conditions that may not require antibiotic use has been documented to be very 
prevalent among healthcare providers. In this study, 76.3% of surveyed healthcare providers 
agreed that antibiotics could be prescribed for all cases of Upper Respiratory Tract Infection 
(URTI). Whilst many healthcare providers agreed that only minimum amount of drugs needed 
should be prescribed for patients, almost half were undecided about the rationality of picking a 
drug they perceived to be effective but not in essential drug list (Table 7). In many healthcare 
settings in developing countries, providers may prescribe drugs more than the need of the patient 
so that the patient may feel happy and satisfied about the consultation (Sachs and Tomson, 
1992). 
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5.6 Factors affecting rational use of drug by healthcare providers 
In this study it was found that the Standing Order was the major factor (60.8%) reported as 
influencing the choice of drug, dosage, and duration of drug treatment (Table10).  This was in 
contrast to findings from another study which identified factors such as perceived demand and 
patient expectation and the influence of medical representatives as the main factors affecting 
prescribing practices of healthcare providers (Oshikoya et al., 2011).  Nevertheless, a significant 
proportion (20.4%) of healthcare providers assessed in this study still admitted they would be 
influenced by the patients‘ demands and expectations in deciding the route of administration of 
prescribed drugs.  This is consistent with the attitude of healthcare providers to rational use of 
drugs in this study as a significant proportion (12.5% and 22.8% strongly agreed and agreed 
respectively) indicated that injections could be prescribed for a patient if he demands for it. In 
many settings in developing countries including Nigeria, injections are believed to work better 
than other drug preparations thereby making patients demand this route of drug administration. 
This results in an overuse of injections by the healthcare providers with all the negative 
connotations.  
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CHAPTER 6 
CONCLUSION AND RECOMMENDATIONS 
 6.1 Conclusion  
This study revealed that the level of understanding and knowledge of rational drug use among 
the majority of healthcare providers was poor and many had little understanding of the concept 
of rational drug use. Knowledge of rational drug use was significantly associated with healthcare 
providers‘ professional status, duration of practice and previous training on rational drug use. 
Surprisingly, CHOs were found to have better knowledge about rational drug use than other 
cadres of PHC healthcare providers, a finding that is likely to be because CHOs training is 
tailored towards prescribing using a standard treatment guideline (Standing Order). While the 
Standing Order, which does not contain detailed information about drugs, was found to be the 
main influence on prescribing and source of information to healthcare providers, drug leaflets 
from pharmaceutical companies also served as important source to a significant proportion.  
 
The attitude of the providers to certain aspects of rational prescribing such as antibiotic and 
injection use was poor, which was reflected in an overuse of antibiotic and injections. Similarly, 
the study showed that generic prescribing and prescribing from the essential drug list by 
healthcare providers was considerably below 100% target. Furthermore, the study revealed that 
the majority of healthcare providers had not received recent training on rational use of drugs. 
 
6.2 Recommendations 
Rational drug use, and especially rational prescribing by healthcare providers, would go a long 
way in improving the quality of healthcare services. It would minimize wastage of resources and 
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prevent hazards associated with unwanted drug interactions and side effects. For significant 
improvements in rational prescribing and drug use among healthcare providers at the PHC level, 
the following recommendations are made based on the findings from this study: 
 
1. Staff skill-mix at primary healthcare facilities should be improved, so that doctors and 
other higher cadres of healthcare providers should take greater responsibility for drug 
prescribing. 
2. The capacities of all prescribing healthcare providers‘ on rational drug use should be 
improved through in-service training such as group- based outreach programmes and a 
system of continuous medical education instituted to promote lifelong learning.  
3. The concept of rational drug use should be incorporated into the curricula of all 
healthcare providers prescribing at the primary care level.  
4. Drug and therapeutic committees should be instituted in every facility at the PHC level to 
improve awareness about rational drug use. 
5. Continuous monitoring and supervision of health providers on rational use of drugs 
should be instituted in health facilities to ensure rational drug use. 
6. Further research into rational use of drugs should be conducted across various 
professional cadres prescribing drugs at PHC level. 
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APPENDICES 
APPENDIX I: DATA COLLECTION TOOLS 
 
TOOL I: DETAILED INDICATOR ENCOUNTER FORM 
 
Name of Health facility:……………………………………. 
Investigator:………………………………………………… 
Date:………………………………………………………….. 
 
Identification no Date  Name  Age  Sex  Prescriber  
     
Health problem Health problem description Code   
  
1.  
2.  
3.  
Drugs  Name and strength Code  Quantity  
 1.   
2.   
3.   
4.   
5.   
6.   
7.   
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Tool II: PRESCRIBING INDICATOR FORM 
Health facility:…………………………………………………………………………………… 
Investigator……………………………………………………………………………………… 
Date:………………………………………………………………………………………… 
S/N Type(R/P)   Date of 
treatment 
Age(yrs) No 
Drugs 
No of 
generics 
Antib 
(0/1) 
Injec 
(0/1) 
No 
on  
EDL 
Diagnosis  
1          
2          
3          
4          
5          
6          
7          
8          
9          
10          
11          
12          
13          
14          
15          
16          
17          
18          
19          
20          
21          
22          
23          
24          
25          
26          
27          
28          
29          
30          
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TOOL III: QUESTIONNAIRE FOR HEALTH PROVIDERS 
SECTION A: SOCIODEMOGRAPHIC CHARACTERISTICS 
1. Sex                                                                           Male         [] Female                 [] 
2. How old are you…………………………………………………………………………………………………………………….. 
3. What is your professional status 
a. Doctor  
b. Nurse 
c. CHO 
d. CHEW 
4. How long have you been working in this capacity?................ 
5. What is your marital status 
a. Single 
b. Married 
c. Divorced 
d. Widowed 
6. What is your religion 
a. Islam  
b. Christianity 
c. Others  
7. What is your ethnic group 
a. Hausa 
b. Fulani 
c. Yoruba 
d. Igbo 
e. others 
SECTION B: KNOWLEDGE OF RATIONAL DRUG USE 
1. What do you understand by rational use of drugs? 
…………………………………………………………………….................................................................................... 
…………………………………………………………………………………………………………………………………………………….. 
2. The following are the steps taken in rational drug prescription practices (1 is the first step and 
five the last step) 
a. Appropriate indication  
b. Appropriate drug choice 
c. Appropriate patient 
d. Appropriate information  
e. Appropriate monitoring 
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3. Rational  drug use include the following 
a.  Choice of drug                         Yes * +            No* +     Don’t Know * +      
b. Dosage of drug                                           Yes [ +            No* +     Don’t Know * + 
c. Route through which drug is given           Yes * +            No* +     Don’t Know * + 
d. Duration of treatment                               Yes * +            No* +     Don’t Know * + 
e. Information about drug to patient          Yes * +            No* +     Don’t Know * + 
f. Number of drugs given                              Yes * +            No* +     Don’t Know * + 
g. Generic/trade name prescribing              Yes * +            No* +     Don’t Know * + 
h. Others ……………………………………………. 
4. Consequences of irrational prescribing include 
       a. Sub-optimal patient care                                  Yes * +            No* +     Don’t Know * + 
       b. Wastage of resources                                        Yes [ ]            No* +     Don’t Know * +  
c .Microbial resistance to antimicrobial             Yes * +            No* +     Don’t Know * +    
d. Adverse drug reactions                                     Yes * +            No* +     Don’t Know * + 
e. Others specify………… 
5. Are you aware of the existence of National Essential Drug list or National Drug Formulary? 
6. Have you attended Rational Drug Related training within the last year?   Yes[]     No [] 
SECTIONC C: ATTITUDE TOWARDS RATIONAL DRUG USE 
Please indicate by ticking how you feel about the statements below on rational drug use (SA= Strongly 
Agree, A= agree, U= Undecided, D= disagree and SA= Strongly Disagree). 
 Item SA A U D SD 
A Optimum  patient care involves how drugs are 
prescribed to patients 
     
B A health worker may prescribe injection for patient if 
a patient demands for it 
     
C Antibiotics should be prescribed for all cases of Upper 
Respiratory Tract Infection(URTI) 
     
D It does not matter whether a health worker prescribe 
in generic or trade name 
     
E More drugs can be prescribed for patients to make 
him happy even if he does not need all the drugs 
     
F Drug that are not in EDL may be prescribed for a 
patients so far it is effective 
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SECTION D: PRACTICE OF RATIONAL DRUG USE  
(For questions 1-5, check last prescription by healthcare provider) 
1. How many drugs did you prescribe for your last patient? ……………………………………………… 
 2.    Does your last prescription contain an antibiotic? ………………………………………………………. 
       3.    Does your last prescription contain an injection? )..........................................................  
4. How many of the drugs in your last prescription were prescribed in generic?  .............. 
5. How many of the drugs in your last prescription are listed in Essential Drug List……………. 
6. Do you routinely use EDL/NDF routinely in your prescription              Yes []                NO[] 
7. What mainly guides the choice of drug(s) you prescribe for your patient? (Indicate by ticking 
the factor with the main influence) 
Factor  Drug choice Dose  Route Duration  
Personal experience     
Routine practice in 
health facility 
    
Available drug in the 
health facility  
    
Cost of drug     
Patient/care giver 
expectation 
    
Promotion by sale 
representative 
    
Essential drug list     
Patient load     
Standing order     
Others      
 
8. Do you have access to Essential Drug List/National Drug Formulary  in this facility    Yes[]    No[] 
9. What is your primary source of information on prescription drug use? 
a. . Promotion by sales representative of drug companies 
b. Advertisement by drug companies 
c. Drug formularies 
d. Others (Specify)………………………………………………………………………. 
10. When was the last time you received any training on rational drug use…………………… 
11. Do you desire more training on rational drug use?     Yes []                        No[] 
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APPENDIX II: PARTICIPANT INFORMATION SHEET 
Drug Prescribing practices among Primary Healthcare providers in a Local Government Area of 
Northwestern Nigeria. 
Date:                     
Interviewer:  
UWC Student no: 2826923 
Tel: _____________ Fax: ________________________ 
E-mail:oguntundedoc@gmail.com 
Institution: University of the Western Cape 
Place at which the interview was conducted: 
Thank you for agreeing to allow me to interview you. What follows is an explanation of the purpose and 
process of this interview.  
1. Information about the interviewer 
I am Oguntunde Olugbenga, a student at the School of Public Health, University of the Western Cape. As 
part of my Masters in Public Health, I am required to carry out a research on prescribing practices of 
primary healthcare providers in Zaria LGA. I am accountable to Ms Hazel Bradley who is contactable at 
c/o SOPH Fax: 021 959 2872 or by e-mail at hbradley@uwc.ac.za 
Here is some information to explain the purpose and usage of my interview.  
2. Purpose and contents of interview:  The purpose of the interview is to assess the level of knowledge 
of rational drug use, drug prescribing practices and factors that influence rational drug use among 
primary healthcare providers in Zaria LGA, Northwestern Nigeria. 
3. The interview process: You shall be given a questionnaire and you will be required to respond to 
questions about your knowledge, attitude and practice of rational use of drugs after which the 
questionnaire will be collected back from you. This may take you about ten minutes to complete. 
4. Anonymity of contributors: At all times, I will keep the source of the information confidential I shall 
keep any other records of your participation locked away at all times, and destroy them after the data 
has been collected. The results of questionnaire will be presented in an aggregated form and not 
traceable to any individual healthcare provider or health facility. No risk will accrue to you for 
participating in this study but your responses may go a long way in understanding drug use by primary 
healthcare providers in this LGA of Northwestern Nigeria. 
 
 
 
 
 
68 
 
 
5. Things that may affect your willingness to participate  
If at any time during the interview you would like not to participate in the study, please feel free to do 
so. I will not be offended and there will be no negative consequences if you would prefer t withdraw your 
participation.  
6. Interviewer's agreement: The contents will be used for the purposes referred to above, but may be 
used for published or unpublished research at a later stage without further consent. Any change from this 
agreement will be renegotiated with you. 
                       
 
Study Coordinator’s Name:  
Dr Olugbenga Oguntunde 
Department of Community Medicine 
Fculty of Medicine 
Ahmadu Bello University, Zaria 
Telephone: 08068107367 
Email: oguntundedoc@gmail.com 
 
Supervisor: Hazel Bradley (hbradley@uwc.ac.za) 
School of Public Health 
University of the Western Cape 
Private Bag X17, Belville 7535 
South Africa 
 
Should you have any question regarding the study or rights as a participant or wish to report any 
problems please contact: 
 
Director of School of Public Health: Prof Uta Lehmann (ulehmann@uwc.ac.za) 
Dean of Community & Health Sciences Faculty: Prof Ratie Mpofu (rmpofu@uwc.ac.za) 
 
This research has been approved by the University of the Western Cape Senate Research 
Committee and Ethics Committee. 
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APPENDIX III: CONSENT FORM 
     CONSENT FORM 
Title of Research Project: Prescribing practices among Primary Health Care providers in a 
Local Government Area of Northwestern Nigeria.    
The study has been described to me in language that I understand and I freely and voluntarily 
agree to participate. My questions about the study have been answered. I understand that my 
identity will not be disclosed and that I may withdraw from the study without giving a reason at 
any time and this will not negatively affect me in any way.   
 
Participant’s name……………………….. 
Participant’s signature……………………………….            
Witness……………………………….            
Date……………………… 
 
Should you have any questions regarding this study or wish to report any problems you have 
experienced related to the study, please contact the study coordinator: 
 
Study Coordinator’s Name:  
Dr Olugbenga Oguntunde 
Department of Community Medicine 
Faculty of Medicine 
Ahmadu Bello University, Zaria 
Telephone: 08068107367 
Email: oguntundedoc@gmail.com 
 
 
 
 
 
 
 
